Association of HLA Class I Genotypes With Severity of Coronavirus Disease-19

This article has been Reviewed by the following groups

Read the full article See related articles

Abstract

Human leukocyte antigen (HLA) class I molecules play a crucial role in the development of a specific immune response to viral infections by presenting viral peptides at the cell surface where they will be further recognized by T cells. In the present manuscript, we explored whether HLA class I genotypes can be associated with the critical course of Coronavirus Disease-19 by searching possible connections between genotypes of deceased patients and their age at death. HLA-A, HLA-B, and HLA-C genotypes of n = 111 deceased patients with COVID-19 (Moscow, Russia) and n = 428 volunteers were identified with next-generation sequencing. Deceased patients were split into two groups according to age at the time of death: n = 26 adult patients aged below 60 and n = 85 elderly patients over 60. With the use of HLA class I genotypes, we developed a risk score (RS) which was associated with the ability to present severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) peptides by the HLA class I molecule set of an individual. The resulting RS was significantly higher in the group of deceased adults compared to elderly adults [ p = 0.00348, area under the receiver operating characteristic curve ( AUC ROC = 0.68)]. In particular, presence of HLA-A * 01:01 allele was associated with high risk, while HLA-A * 02:01 and HLA-A * 03:01 mainly contributed to low risk. The analysis of patients with homozygosity strongly highlighted these results: homozygosity by HLA-A * 01:01 accompanied early deaths, while only one HLA-A * 02:01 homozygote died before 60 years of age. Application of the constructed RS model to an independent Spanish patients cohort ( n = 45) revealed that the score was also associated with the severity of the disease. The obtained results suggest the important role of HLA class I peptide presentation in the development of a specific immune response to COVID-19.

Article activity feed

  1. SciScore for 10.1101/2020.11.19.20234567: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    NIH rigor criteria are not applicable to paper type.

    Table 2: Resources

    Software and Algorithms
    SentencesResources
    HLA-A, HLA-B and HLA-C genes were sequenced with MiSeq platform (Illumina, San Diego, CA, USA) through exons 2 to 4 in both directions using reagent kit HLA-Expert (DNA-Technology LLC, Moscow, Russia) and annotated using the database of the human major histocompatibility complex sequences IMGT/HLA v3.41.0 [12].
    MiSeq
    suggested: (A5-miseq, RRID:SCR_012148)
    IMGT/HLA
    suggested: (IMGT/HLA, RRID:SCR_002971)
    Clustal Omega v1.2.4 was used to construct multiple sequence alignment for each viral protein [14].
    Clustal Omega
    suggested: (Clustal Omega, RRID:SCR_001591)
    Specifically, for each amino acid of each viral protein we assessed the probability of proteasomal cleavage in the considered site using NetChop v3.1 [16].
    NetChop
    suggested: None
    Binding affinities were predicted using netMHCpan v4.1 [17] for all viral peptides (n = 15314) and HLA alleles present in our cohorts of deceased and control patients (n = 107).
    netMHCpan
    suggested: (NetMHCpan Server, RRID:SCR_018182)
    The following functions from scipy.stats Python module [18] were used to conduct statistical testing: fisher exact for Fisher’s exact test, mannwhitneyu for Mann-Whitney U test.
    scipy
    suggested: (SciPy, RRID:SCR_008058)
    Python
    suggested: (IPython, RRID:SCR_001658)
    Principal component analysis was conducted with scikit-learn Python module [19].
    scikit-learn
    suggested: (scikit-learn, RRID:SCR_002577)
    Plots were constructed with Seaborn and Matplotlib [20].
    Matplotlib
    suggested: (MatPlotLib, RRID:SCR_008624)

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).


    Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.

    Results from TrialIdentifier: No clinical trial numbers were referenced.


    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.


    Results from JetFighter: We did not find any issues relating to colormaps.


    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.